DXCM

HOLD

DexCom Inc.

Health Care

1.29

PEGY ratio

Rank #254

Why This Matters

This stock appears fairly valued relative to its growth and dividend yield. Strong projected growth of 31.7% annually over 5 years.

DXCM is fairly valued at 32.1x earnings with 25.0% capped growth (actual 31.7%) (no dividend) (PEGY 1.29). The stock is priced close to what its growth and income profile would suggest.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.
• Growth rate capped at 25% for PEGY calculation (actual: 31.7%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.

Scan date: 2026-06-02

Valuation

32.1x

P/E Ratio

Growth

31.7%

5yr EPS

Income

0.0%

Div Yield

PEGY Components

PEGY Score1.29

Denominator25.0%

EPS (TTM)$2.33

Market Data

Price$74.87

ExchangeNASDAQ

S&P 500Nasdaq 100

What Changed

PEGY Score

1.24→1.29(+0.05)

Rank

#242→#254(12 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only